|
|
|
市場調査レポート
冠動脈疾患の診断と治療に関する新技術：2007年
Emerging Technologies for the Diagnosis and Treatment of Coronary Artery Disease 2007
|
Abstract
Coronary artery disease is a leading cause of death in the developed world
and, as such, is at the forefront of medical research.
Table of Contents
TABLE OF CONTENTS
LIST OF EXHIBITS
EXECUTIVE SUMMARY
METHODOLOGY
1.0 CORONARY ARTERY DISEASE
- 1.1 Introduction
- 1.2 An Overview of Coronary Artery Disease
- 1.3 Epidemiology
- 1.4 Existing Diagnosis and Treatment Options for Coronary Artery Disease
- 1.4.1 Diagnosis
- 1.4.2 Treatment
- 1.5 Future Outlook
2.0 DIAGNOSTIC IMAGING DEVICES
- 2.1 Overview
- 2.2 Intravascular Ultrasound
- 2.2.1 Technology Overview
- 2.2.2 Market Potential
- 2.2.3 Competitor Insights
- 2.3 Vulnerable Plaque Diagnosis
- 2.3.1 Technology Overview
- 2.3.1.1 Computed Tomography
- 2.3.1.2 Magnetic Resonance Imaging
- 2.3.1.3 Near-Infrared Spectroscopy
- 2.3.1.4 Optical Coherence Tomography
- 2.3.1.5 Thermography
- 2.3.2 Market Potential
- 2.3.3 Competitor Insights
- 2.3.3.1 Computed Tomography
- 2.3.3.2 Magnetic Resonance Imaging
- 2.3.3.3 Near-Infrared Spectroscopy
- 2.3.3.4 Optical Coherence Tomography
- 2.3.3.5 Thermography
3.0 REVASCULARIZATION DEVICES
- 3.1 Overview
- 3.2 Novel Stent Technologies
- 3.2.1 Technology Overview
- 3.2.1.1 Bioabsorbable Stents
- 3.2.1.2 Specially Coated Drug-Eluting Stents
- 3.2.2 Market Potential
- 3.2.2.1 Bioabsorbable Stents
- 3.2.2.2 Specially Coated Drug-Eluting Stents
- 3.2.2.3 Overall Coronary Stent Market
- 3.2.3 Competitor Insights
- 3.2.3.1 Bioabsorbable Stents
- 3.2.3.2 Specially Coated Drug-Eluting Stents
- 3.3 Synthetic Grafts
- 3.3.1 Technology Overview
- 3.3.2 Market Potential
- 3.3.3 Competitor Insights
- 3.4 Remote Navigation Technologies
- 3.4.1 Technology Overview
- 3.4.2 Market Potential
- 3.4.3 Competitor Insights
4.0 NEOVASCULARIZATION THERAPIES
- 4.1 Overview
- 4.2 Therapeutic Angiogenesis
- 4.2.1 Technology Overview
- 4.2.1.1 Gene Therapy
- 4.2.1.2 Stem Cell Therapy
- 4.2.2 Market Potential
- 4.2.3 Competitor Insights
- 4.2.3.1 Gene Therapy
- 4.2.3.2 Stem Cell Therapy
APPENDIX A: MRG ACRONYMS AND INITIALISMS
APPENDIX B: ADDITIONAL COMPETITOR INFORMATION
List of Exhibits
EXECUTIVE SUMMARY
- Exhibit 1: New Imaging Technology Procedures, US, 2009-2018
- Exhibit 2: PCIs, by Type, US, 2018
- Exhibit 3: Therapeutic Angiogenesis Procedures, US, 2013-2018
CHAPTER 1: CORONARY ARTERY DISEASE
- Exhibit 4: Frequently Used CAD Terminology
- Exhibit 5: Stages of Lesion Development
- Exhibit 6: Common CAD Risk Factors
- Exhibit 7: Global Life Expectancy, 2006
- Exhibit 8: CAD Incidence, by Region, 2007-2013 (Tabular Format)
- Exhibit 9: Symptoms of CAD
- Exhibit 10: CAD Treatment Options
CHAPTER 2: DIAGNOSTIC IMAGING DEVICES
- Exhibit 11: IVUS Procedures, by Region, 2006-2011
- Exhibit 12: New Imaging Technology Penetration, as a % of Total, US,
2009-2018
- Exhibit 13: New Imaging Technology Penetration, US, 2009-2018
CHAPTER 3: REVASCULARIZATION DEVICES
- Exhibit 14: BAS Procedures, US, 2012-2018
- Exhibit 15: BAS Penetration, US, 2012-2018
- Exhibit 16: SCDES Procedures, US, 2010-2018
- Exhibit 17: SCDES Penetration, US, 2010-2018
- Exhibit 18: PCIs, by Type, as a % of Total, US, 2008-2018
- Exhibit 19: PCIs, by Type, US, 2008-2018
- Exhibit 20: PCI Growth, by Type, US, 2008-2018
- Exhibit 21: BAS in Development, 2007
- Exhibit 22: BAS Material Absorption Time
- Exhibit 23: Polymer-Free and Bioabsorbable Polymer-Coated Stents, 2007
- Exhibit 24: Synthetic Graft Procedures, 2011-2018
- Exhibit 25: Synthetic Graft Penetration, 2011-2018
- Exhibit 26: RNT Procedures, 2008-2018
- Exhibit 27: RNT Penetration, US, 2008-2018
CHAPTER 4: NEOVASCULARIZATION THERAPIES
- Exhibit 28: Therapeutic Angiogenesis Procedures, US, 2013-2018
- Exhibit 29: Therapeutic Angiogenesis Procedure Penetration, US, 2013-2018
APPENDIX A: MRG ACRONYMS AND INITIALISMS
APPENDIX B: ADDITIONAL COMPETITOR INFORMATION
|
 |
